InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: concordia post# 80864

Sunday, 02/18/2018 2:49:06 PM

Sunday, February 18, 2018 2:49:06 PM

Post# of 144813
Nov 4, 2013 Nuvilex Announces Cloning of Cells

The contents of the vial were tested and found to be free of the “adventitious agents”



Well, one has to admit Kenny has cleaned up such phrases in the current recycling of past PRs. LOL

Time for Predictions...

The promised IND filing by 30-Mar will be missed. A subsequent PR will explain it's so complicated. Then repeat the 2016 promise: IND by the end of the year. So goes 2018. IF and whenever the mythical IND appears, the CT status will permanently be in a "recruiting" status for years to come. Higher probability the mythical IND will remain mythical. Kenny pivoting back to, recycling the diabetes, and the THC PRs. As long as Kenny can dump 30K shares a month, and PMCB can dump enough stock to pay for his $350K salary, he'll be happy.

Only in the world of Microcrap Biotechs do you have a treatment overlooked by the entire Pharma sector since 1998. Where it takes 4 yrs plus, and counting to file an IND - soooo complicated. Meanwhile the ball keeps on bouncing. A couple of Phase 2, and Phase 3 CTs to report results in 2018.



The Jewel of the Mind is Colored with the Hue of what it Imagines

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News